Insider Shareholders with Direct Ownership of Editas Medicine, Inc. (EDIT)
This section provides a comprehensive overview of the insiders with direct ownership of Editas Medicine, Inc. (EDIT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Editas Medicine, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 411,780 | 98,056 | 313,724 $909,799 | 7 |
Sep 04, 2024
Reduced 0.49%
|
|
|
Viking Global Investors Lp
> 10% Shareholder |
2,729,808 | 0 | 266,782 $773,667 | 1 |
Feb 08, 2015
Added 1.96%
|
|
Baisong Mei
EVP, CHIEF MEDICAL OFFICER |
166,187 | 32,292 | 133,895 $388,295 | 8 |
Sep 04, 2024
Reduced 0.39%
|
|
Erick Lucera
EVP, CHIEF FINANCIAL OFFICER |
139,166 | 22,337 | 116,829 $338,804 | 3 |
May 20, 2024
Reduced 16.05%
|
|
Michelle Robertson
EVP, CHIEF FINANCIAL OFFICER |
104,773 | 18,163 | 106,610 $309,169 | 18 |
May 11, 2023
Reduced 0.88%
|
|
James C Mullen
CEO |
97,955 | 32,057 | 75,898 $220,104 | 5 |
Jan 03, 2022
Reduced 19.39%
|
|
Bruce Eaton
EVP, CBO AND CTO |
57,765 | 11,287 | 74,791 $216,893 | 26 |
Dec 05, 2023
Reduced 0.14%
|
|
Linda Burkly
EVP, CHIEF SCIENTIFIC OFFICER |
85,022 | 11,886 | 73,136 $212,094 | 3 |
Jul 25, 2024
Reduced 13.98%
|
|
Jessica Hopfield
Director |
50,800 | 0 | 67,700 $196,330 | 2 |
May 13, 2024
Added 39.93%
|
|
Mark S Shearman
EVP, CHIEF SCIENTIFIC OFFICER |
73,494 | 7,935 | 65,559 $190,121 | 5 |
Feb 13, 2023
Reduced 4.08%
|
|
Cynthia Collins
CEO |
0 | 1,262 | 43,760 $126,904 | 1 |
Feb 09, 2021
Reduced 2.8%
|
|
Charles Albright
EVP/Chief Scientific Officer |
40,000 | 43,228 | 24,907 $72,230 | 8 |
Dec 15, 2020
Reduced 0.8%
|
|
Lisa Anne Michaels
EVP/Chief Medical Officer |
24,243 | 1,568 | 22,675 $65,757 | 3 |
Dec 22, 2021
Added 15.76%
|